换一批
换一批摘要The median follow-up of the malignant glioma patients who received surgical resection combined with radiochemotherapy is 16 months.The recurrence of malignant glioma is unavoidable.Although the patient with recurrent glioblastoma has multiple choices of therapy,the 5-year survival rate is still less than 5％,and the average survival time is less than 12 months.[1] Currently,there is no single second-line drug can have survival benefits.
更多相关知识
栏目名称
Comments
DOI
10.4103/0366-6999.244121
发布时间
2018-12-07
- 浏览8
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
